MorphoSys Share Price Performance
Year to date, the MorphoSys share price decreased by 15% at the end of the second quarter, in line with the major benchmark indices which also went down significantly. The TecDAX decreased by 11% during the first six months, the NASDAQ Biotechnology Index by 6%. By comparison, a basket of international antibody companies (Source: BioCentury) decreased by 20%.
The MorphoSys Share (January 4, 2010 = 100%)
